This is the competitive renewal for the Medical Scientist Training Program (MSTP) at the Icahn School of Medicine at Mount Sinai (ISMMS). The MD/PhD program at Mount Sinai began in 1971 and in 1977 was awarded its first funding from NIGMS as an MSTP. For 39 years, our mission has been to educate future physician-scientists in a rigorous, integrated joint degree program. The program features an open and collaborative environment that fosters innovation in fundamental and translational biomedical research. Our trainees become independent investigators and leaders who apply basic science discoveries to improve healthcare in all communities. A large percentage of the trainees (82%) continue to pursue biomedical research (academic, pharma, federal agencies). During the past five years, ISMMS has continued to increase in ranking as one of the nation's top translational biomedical research institutions, 15th in research funding among US medical schools. Based on an ambitious Strategic Plan, ISMMS established a series of institutes that bridge basic science and clinical departments, strengthening our translational goals. A major centerpiece is a new translational research building, the Hess Center for Science and Medicine, that increased our research capacity by 30% and supported the recruitment of >200 new faculty, of whom 77 have joined the MSTP training faculty. In parallel, the numbers of highly qualified applicants to our MSTP have steadily increased. Our students achieve at a high level, as measured by publications, receipt of independent fellowship support, and matching in top residency programs. ISMMS has an outstanding record in the recruitment and retention of a diverse body of medical and graduate students. The MSTP has implemented a new program-specific integrated curriculum and also features courses that facilitate smooth transitions from preclinical to PhD and then from PhD to clinical training. Our MSTP also provides significant flexibility in the path through the program and opportunities for tailoring to the needs of the student. The Dean has invested considerable resources to build and strengthen the MD/PhD Program. In this application, we request funding to continue the MSTP beyond year 40. The MD/PhD Program at ISMMS provides an outstanding foundation for its students to develop successful careers as physician-scientists.

Public Health Relevance

The Medical Scientist Training Program (MSTP) at the Icahn School of Medicine at Mount Sinai seeks to educate future physician-scientists in a rigorous, integrated training environment. Our leadership is committed to the education of forward thinking trainees who are passionate about biomedical research, collaborative problem solving, and social advocacy and who will develop into independent investigators and leaders in translational medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007280-41
Application #
9279938
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
1977-07-01
Project End
2022-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
41
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Heitman, Nicholas; Saxena, Nivedita; Rendl, Michael (2018) Advancing insights into stem cell niche complexities with next-generation technologies. Curr Opin Cell Biol 55:87-95
Kaniskan, H Ümit; Martini, Michael L; Jin, Jian (2018) Inhibitors of Protein Methyltransferases and Demethylases. Chem Rev 118:989-1068
Kim, Jun S; Merrill, Robert K; Arvind, Varun et al. (2018) Examining the Ability of Artificial Neural Networks Machine Learning Models to Accurately Predict Complications Following Posterior Lumbar Spine Fusion. Spine (Phila Pa 1976) 43:853-860
Osman, Nebiyu S; Cheung, Zoe B; Hussain, Awais K et al. (2018) Outcomes and Complications Following Laminectomy Alone for Thoracic Myelopathy due to Ossified Ligamentum Flavum: A Systematic Review and Meta-Analysis. Spine (Phila Pa 1976) 43:E842-E848
Jiang, Guochun; Nguyen, Don; Archin, Nancie M et al. (2018) HIV latency is reversed by ACSS2-driven histone crotonylation. J Clin Invest 128:1190-1198
Mayourian, Joshua; Ceholski, Delaine K; Gonzalez, David M et al. (2018) Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling. Circ Res 122:167-183
Miller, M L; Ren, Y; Szutorisz, H et al. (2018) Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Mol Psychiatry 23:1328-1335
Bollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina et al. (2017) Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut 66:1286-1296
Edlow, Brian L; Chatelle, Camille; Spencer, Camille A et al. (2017) Early detection of consciousness in patients with acute severe traumatic brain injury. Brain 140:2399-2414
Goff, Peter H; Hayashi, Tomoko; He, Wenqian et al. (2017) Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice. J Virol 91:

Showing the most recent 10 out of 152 publications